Eton Pharmaceuticals (ETON) News Today → The World’s Richest Man Blindsided by AI (From Banyan Hill Publishing) (Ad) Free ETON Stock Alerts $3.63 +0.08 (+2.25%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 12 at 7:37 PM | finance.yahoo.comEton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats ExpectationsMay 12 at 4:48 AM | americanbankingnews.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 41.0% in AprilMay 10, 2024 | marketbeat.comEton Pharmaceuticals (NASDAQ:ETON) Posts Earnings Results, Misses Expectations By $0.01 EPSEton Pharmaceuticals (NASDAQ:ETON - Get Free Report) released its earnings results on Thursday. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.01). Eton Pharmaceuticals had a negative return on equity of 6.21% and a negative net margin of 2.96%. The firm had revenue of $7.97 million during the quarter, compared to analysts' expectations of $8.30 million. During the same period in the previous year, the firm posted ($0.10) earnings per share.May 10, 2024 | finance.yahoo.comQ1 2024 Eton Pharmaceuticals Inc Earnings CallMay 9, 2024 | globenewswire.comEton Pharmaceuticals Reports First Quarter 2024 Financial ResultsMay 8, 2024 | markets.businessinsider.comHere's what Wall Street expects from Eton Pharmaceuticals's earnings reportMay 8, 2024 | americanbankingnews.comEton Pharmaceuticals (NASDAQ:ETON) Coverage Initiated at Craig HallumMay 7, 2024 | msn.comCraig-Hallum Initiates Coverage of Eton Pharmaceuticals (ETON) with Buy RecommendationMay 1, 2024 | globenewswire.comEton Pharmaceuticals to Present at the Citizens JMP Life Sciences ConferenceMay 1, 2024 | finance.yahoo.comPhenylketonuria (PKU) Global Clinical Trials Review 2024: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor TypeApril 30, 2024 | markets.businessinsider.comEton Pharmaceuticals Announces NDA Submission For ET-400April 30, 2024 | globenewswire.comEton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)April 29, 2024 | globenewswire.comEton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024April 26, 2024 | marketbeat.comAcuitas Investments LLC Raises Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Acuitas Investments LLC boosted its stake in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 124.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 492,054 shares of the company's stockApril 26, 2024 | msn.comPE Advent International queues up for a stake in Apollo 24/7April 15, 2024 | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest UpdateEton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) saw a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 220,400 shares, a drop of 9.3% from the March 15th total of 242,900 shares. Based on an average trading volume of 70,600 shares, the days-to-cover ratio is currently 3.1 days. Currently, 1.0% of the shares of the company are sold short.April 2, 2024 | marketbeat.comShort Interest in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Expands By 6.9%Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 242,900 shares, a growth of 6.9% from the February 29th total of 227,200 shares. Based on an average daily trading volume, of 75,100 shares, the short-interest ratio is presently 3.2 days. Approximately 1.1% of the company's shares are sold short.March 22, 2024 | markets.businessinsider.comEton Pharma Buys U.S. Rights To PKU GOLIKE From Relief TherapeuticsMarch 22, 2024 | finance.yahoo.comRelief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKEMarch 22, 2024 | globenewswire.comEton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for PhenylketonuriaMarch 17, 2024 | theguardian.com‘I don’t think I developed emotionally’: Earl Spencer on the pain of boarding-school abuseMarch 17, 2024 | investing.comEarnings call: Eton Pharmaceuticals reports robust Q4 growthMarch 16, 2024 | finance.yahoo.comETON Apr 2024 5.000 callMarch 16, 2024 | seekingalpha.comEton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call TranscriptMarch 16, 2024 | benzinga.comRecap: Eton Pharmaceuticals Q4 EarningsMarch 15, 2024 | finance.yahoo.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comQ4 2023 Eton Pharmaceuticals Inc Earnings CallMarch 14, 2024 | finance.yahoo.comEton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...March 14, 2024 | globenewswire.comEton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 13, 2024 | benzinga.comEton Pharmaceuticals Earnings PreviewMarch 13, 2024 | msn.comEton Pharmaceuticals Q4 2023 Earnings PreviewMarch 13, 2024 | markets.businessinsider.comEton Pharmaceuticals earnings preview: what Wall Street is expectingMarch 13, 2024 | msn.comEarl Spencer’s horrific first experience of sex was all too typical for an upper-class maleMarch 12, 2024 | thetimes.co.ukCharles Spencer: ‘Boarding school killed a part of me’March 11, 2024 | washingtonpost.comPrincess Di’s brother, Charles Spencer, recounts childhood horrorsMarch 11, 2024 | msn.comCharles Spencer, Princess Diana’s brother, speaks out about ‘devastating’ abuse at British boarding schoolMarch 11, 2024 | thetimes.co.ukBoris Johnson’s secret flight to meet autocrat Maduro in VenezuelaMarch 11, 2024 | msn.comEarl Spencer reveals abuse at boarding schoolFebruary 29, 2024 | globenewswire.comEton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024February 23, 2024 | marketbeat.com256,623 Shares in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Acquired by EAM Investors LLCEAM Investors LLC acquired a new stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 256,623 shares of the company's stock, valued at approximately $1,0February 22, 2024 | benzinga.comEton Pharmaceuticals Stock (NASDAQ:ETON) Dividends: History, Yield and DatesFebruary 21, 2024 | globenewswire.comEton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid FormulationFebruary 6, 2024 | marketbeat.comEton Pharmaceuticals (NASDAQ:ETON) Stock Price Up 2%Eton Pharmaceuticals (NASDAQ:ETON) Trading 2% HigherJanuary 23, 2024 | finance.yahoo.comEton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years agoJanuary 10, 2024 | marketbeat.comAcuitas Investments LLC Has $913,000 Stock Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Acuitas Investments LLC lessened its holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 57.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 219,000 shares of the company's stock after selling 291,0December 27, 2023 | benzinga.comEton Pharmaceuticals Stock (NASDAQ:ETON), Analyst Ratings, Price Targets, PredictionsDecember 14, 2023 | finance.yahoo.com5 Under-$15 Stocks Wall Street Analysts Recommend BuyingDecember 13, 2023 | finance.yahoo.comOne Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Analyst Just Made A Major Cut To Next Year's EstimatesDecember 13, 2023 | marketbeat.comResearch Analysts Set Expectations for Eton Pharmaceuticals, Inc.'s FY2023 Earnings (NASDAQ:ETON)Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Analysts at HC Wainwright issued their FY2023 earnings estimates for shares of Eton Pharmaceuticals in a research note issued to investors on Monday, December 11th. HC Wainwright analyst R. Selvaraju forecasts that the company will post earNovember 26, 2023 | morningstar.comEton Pharmaceuticals Inc ETON Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address Look Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman. Get the full story here. ETON Media Mentions By Week ETON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETON News Sentiment▼0.030.57▲Average Medical News Sentiment ETON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETON Articles This Week▼111▲ETON Articles Average Week Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CLSD News ACRS News ORMP News ANIX News MIST News ADAG News BYSI News PRPH News ONCY News IOBT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETON) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDid Intel Just Dethrone Nvidia?Chaikin AnalyticsDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmerica’s worst nightmare?Porter & CompanyHow to Make 100X on the AI BoomInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
